Security key
75382E109
RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT)
CUSIP: 75382E109
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 27,725,634
- Total 13F shares
- 31,808,667
- Share change
- -141,953
- Total reported value
- $97,015,342
- Put/Call ratio
- 70%
- Reported price per share
- $3.05
- Number of holders
- 100
- Value change
- -$20,514,565
- Number of buys
- 51
- Number of sells
- 71
Security identity
Holder snapshot
Report period
Q2 2024
Institutions
100
Top holders
10
RAPT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
RAPT Therapeutics, Inc. SEC filings
RAPT Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75382E109
Recent filing periods:
Ownership snapshot
Top reported holders of RAPT - RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
FMR LLC
13D/G signal
—
Evidence rows
15
Latest as of
31 Mar 2024
13F
Lead comparable stake: 19%
Showing 1-6 of 15 holder rows.
Rank 1 holder
FMR LLC
13F
- Ownership
- 19%
- Position
- $46.87M
Rank 2 holder
Column Group LLC
13F
- Ownership
- 9.7%
- Position
- $24.07M
Rank 3 holder
VANGUARD GROUP INC
13F
- Ownership
- 9%
- Position
- $22.39M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
19%
|
$46,872,502
5,219,655 shares
|
— | 31 Mar 2024 |
| Column Group LLC |
13F
Company
|
9.7%
|
$24,071,977
2,680,621 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9%
|
$22,385,792
2,492,850 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
8.9%
|
$22,199,933
2,472,153 shares
|
— | 31 Mar 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
7.3%
|
$18,214,000
2,028,166 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
6.9%
|
$17,109,900
1,905,334 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
100
Shares
31,808,667
Rows available
100
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
120
Q2 2024 holders
100
Holder diff
-20
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend